KLRA
Kailera Therapeutics, Inc. Common StockNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$3.24B
P/E Ratio
—
EPS
$-1.26
Beta
—
52W High
$28.23
52W Low
$16.00
50-Day MA
$24.48
200-Day MA
$24.48
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Kailera Therapeutics, Inc. Common Stock
None
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-158.03M |
| Operating Margin | 0.00% |
| Return on Equity | -36.90% |
| Return on Assets | -22.70% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | — |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $129.54M |
| Float | 8,170 |
| % Insiders | 0.00% |
| % Institutions | 37.70% |
More HEALTHCARE Stocks
Data last updated: 5/2/2026